<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ketendo</journal-id><journal-title-group><journal-title xml:lang="ru">Клиническая и экспериментальная тиреоидология</journal-title><trans-title-group xml:lang="en"><trans-title>Clinical and experimental thyroidology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1995-5472</issn><issn pub-type="epub">2310-3787</issn><publisher><publisher-name>Endocrinology Research Centre</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14341/CET201410232-37</article-id><article-id custom-type="elpub" pub-id-type="custom">ketendo-6748</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Articles</subject></subj-group></article-categories><title-group><article-title>Оценка результатов повторных ТАБ у пациентов с узловым коллоидным зобом (анализ собственных данных и обзор литературы)</article-title><trans-title-group xml:lang="en"><trans-title>Evaluation of the Results of Repeated FNA in Patients with Nodular Colloid Goiter</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Semkina</surname><given-names>G V</given-names></name></name-alternatives><bio xml:lang="ru"><p>аспирант ФГБУ “Эндокринологический научный центр”; ФГБУ “Эндокринологический научный центр”</p></bio><email xlink:type="simple">-</email></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Abrosimov</surname><given-names>A U</given-names></name></name-alternatives><bio xml:lang="ru"><p>доктор мед. наук, профессор, заведующий клинико#морфологическим отделом ФГБУ “Медицинский радиологический научный центр” Минздравсоцразвития России; ФГБУ “Медицинский радиологический научный центр”</p></bio><email xlink:type="simple">-</email></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Abdulhabirova</surname><given-names>F M</given-names></name></name-alternatives><bio xml:lang="ru"><p>кандидат мед. наук, ведущий научный сотрудник отделения терапии с группой патологии метаболизма и ожирения ФГБУ “Эндокринологический научный центр”; ФГБУ “Эндокринологический научный центр”</p></bio><email xlink:type="simple">-</email></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Vanushko</surname><given-names>V E</given-names></name></name-alternatives><bio xml:lang="ru"><p>доктор мед. наук, главный научный сотрудник отдела хирургии эндокринных органов ФГБУ “Эндокринологический научный центр”; ФГБУ “Эндокринологический научный центр”</p></bio><email xlink:type="simple">vanushko@hotmail.com</email></contrib></contrib-group><pub-date pub-type="collection"><year>2014</year></pub-date><pub-date pub-type="epub"><day>15</day><month>06</month><year>2014</year></pub-date><volume>10</volume><issue>2</issue><issue-title>ТОМ 10, №2 (2014)</issue-title><fpage>32</fpage><lpage>37</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Semkina G.V., Abrosimov A.U., Abdulhabirova F.M., Vanushko V.E., 2014</copyright-statement><copyright-year>2014</copyright-year><copyright-holder xml:lang="ru">Semkina G.V., Abrosimov A.U., Abdulhabirova F.M., Vanushko V.E.</copyright-holder><copyright-holder xml:lang="en">Semkina G.V., Abrosimov A.U., Abdulhabirova F.M., Vanushko V.E.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.cet-endojournals.ru/jour/article/view/6748">https://www.cet-endojournals.ru/jour/article/view/6748</self-uri><abstract><p>Статья посвящена актуальности применения тонкоигольной аспирационной биопсии ( ТАБ), а также целесообразности проведения повторной (ТАБ) у пациентов с первоначально доброкачественным заключением. В данном исследовании участвовало 120 пациентов, которым выполнили ТАБ, по результатам которой был диагностирован узловой коллоидный зоб. При проведении повторной пункции пациентов с доброкачественным новообразованием щитовидной железы цитологический диагноз сменился у 16,6% больных ( n = 20), при этом смена заключения с доброкачественного на “подозрительное на злокачественное” произошла всего у одного больного (0,8%). Длительное наблюдение пациентов с изначально доброкачественным заключением приводит к увеличению числа повторных биопсий, что не только невыгодно, с точки зрения финансирования, но и неинформативно, так как процент выявленных при этом злокачественных новообразований статистически незначим. Представленное выше наблюдение показало, что проведение повторной ТАБ пациентам с доказанным доброкачественным новообразованием щитовидной железы нецелесообразно даже при наличии данных за рост узла и изменение концентрации ТТГ и независимо от возраста.</p></abstract><trans-abstract xml:lang="en"><p>Article is devoted to the relevance of the application of needle aspiration (FNA), as well as the feasibility of re (FNA) in patients with initially benign thyroid nodules. The study involved 120 patients who underwent FNA, the results of which were diagnosed nodular colloid goiter. During repeated FNA of patients with benign thyroid cytologic diagnosis changed in 16.6% of patients ( n = 20), and the conclusion from benign to “suspicious for malignancy” occurred in one patient (0.8%). Long-term observation of patients with initially benign conclusion leads to an increased number of repeat FNAs that not only beneficial in terms of funding, but uninformative, as the percentage identified of malignancies statistically insignificant. The above observation showed that the use of re-FNA in patients with proven benign thyroid nodules impractical even when data are available for the growth of the nodules and the change in concentration of TSH and regardless of age.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>тонкоигольная аспирационная биопсия</kwd><kwd>узловой зоб</kwd><kwd>уровень ТТГ</kwd></kwd-group><kwd-group xml:lang="en"><kwd>Fine-needle aspiration biopsy</kwd><kwd>nodular goiter</kwd><kwd>TSH levels</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Singer PA, Cooper DS, Daniels GH et al. Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer. Arch Intern Med. 1996;156:2165-2172.</mixed-citation><mixed-citation xml:lang="en">Singer PA, Cooper DS, Daniels GH et al. Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer. Arch Intern Med. 1996;156:2165-2172.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Wong CKM, Wheeler MH. Thyroid nodules: rational management. World J Surg. 2000;24:934-941.</mixed-citation><mixed-citation xml:lang="en">Wong CKM, Wheeler MH. Thyroid nodules: rational management. World J Surg. 2000;24:934-941.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Hegedus L, Bonnema SJ, Bennedbæk FN. Management of simple nodular goiter: current status and future perspectives. Endocr Rev. 2003;24:102-132.</mixed-citation><mixed-citation xml:lang="en">Hegedus L, Bonnema SJ, Bennedbæk FN. Management of simple nodular goiter: current status and future perspectives. Endocr Rev. 2003;24:102-132.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Hegedus L. The thyroid nodule. N Eng J Med. 2004;351:1764-1771.</mixed-citation><mixed-citation xml:lang="en">Hegedus L. The thyroid nodule. N Eng J Med. 2004;351:1764-1771.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Singh RS, Wang HH. Timing of repeat thyroid fine-needle aspiration in the management of thyroid nodules. Acta Cytologica. 2011;55:544-548.</mixed-citation><mixed-citation xml:lang="en">Singh RS, Wang HH. Timing of repeat thyroid fine-needle aspiration in the management of thyroid nodules. Acta Cytologica. 2011;55:544-548.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Lawrence W Jr, Kaplan BJ. Diagnosis and management of patients with thyroid nodules. J Surg Oncol. 2002;80:157-170.</mixed-citation><mixed-citation xml:lang="en">Lawrence W Jr, Kaplan BJ. Diagnosis and management of patients with thyroid nodules. J Surg Oncol. 2002;80:157-170.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Chehade JM, Silverberg AB, Kim J et al. Role of repeated fine-needle aspiration of thyroid nodules with benign cytologic features. Endocr Pract. 2001;7:237-243.</mixed-citation><mixed-citation xml:lang="en">Chehade JM, Silverberg AB, Kim J et al. Role of repeated fine-needle aspiration of thyroid nodules with benign cytologic features. Endocr Pract. 2001;7:237-243.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Flanagan MB, Ohori NP, Carty SE, Hunt JL. Repeat thyroid nodule fine-needle aspiration in patients with initial benign cytologic results. Am J Clin Pathol. 2006;125:698-702.</mixed-citation><mixed-citation xml:lang="en">Flanagan MB, Ohori NP, Carty SE, Hunt JL. Repeat thyroid nodule fine-needle aspiration in patients with initial benign cytologic results. Am J Clin Pathol. 2006;125:698-702.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Aguilar J, Rodriguez JM, Flores B et al. Value of repeated fine-needle aspiration cytology and cytologic experience in the management of thyroid nodules. Otolaryngol Head Neck Surg. 1998;119:121-124.</mixed-citation><mixed-citation xml:lang="en">Aguilar J, Rodriguez JM, Flores B et al. Value of repeated fine-needle aspiration cytology and cytologic experience in the management of thyroid nodules. Otolaryngol Head Neck Surg. 1998;119:121-124.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Merchant SH, Izquierdo R, Khurana KK. Is repeated fine-needle aspiration cytology useful in the management of patients with benign nodular thyroid disease? Thyroid. 2000;10:489-492.</mixed-citation><mixed-citation xml:lang="en">Merchant SH, Izquierdo R, Khurana KK. Is repeated fine-needle aspiration cytology useful in the management of patients with benign nodular thyroid disease? Thyroid. 2000;10:489-492.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Orlandi A, Puscar A, Capriata E et al. Repeated fine-needle aspiration of the thyroid in benign nodular thyroid disease: critical evaluation of long-term follow-up. Thyroid. 2005;15:274-278.</mixed-citation><mixed-citation xml:lang="en">Orlandi A, Puscar A, Capriata E et al. Repeated fine-needle aspiration of the thyroid in benign nodular thyroid disease: critical evaluation of long-term follow-up. Thyroid. 2005;15:274-278.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Oertel YC, Miyahara-Felipe L, Mendoza MG, Yu K. Value of repeated fine needle aspirations of the thyroid: An analysis of over ten thousand FNAs. Thyroid. 2007;17:1061-1066.</mixed-citation><mixed-citation xml:lang="en">Oertel YC, Miyahara-Felipe L, Mendoza MG, Yu K. Value of repeated fine needle aspirations of the thyroid: An analysis of over ten thousand FNAs. Thyroid. 2007;17:1061-1066.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Shin JH, Han BK, Ko K et al. Value of repeat ultrasound-guided fine-needle aspiration in nodules with benign cytological diagnosis. Acta Radiol. 2006;47:469-473.</mixed-citation><mixed-citation xml:lang="en">Shin JH, Han BK, Ko K et al. Value of repeat ultrasound-guided fine-needle aspiration in nodules with benign cytological diagnosis. Acta Radiol. 2006;47:469-473.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Lee S, Skelton TS, Zheng F et al. The biopsy-proven benign thyroid nodule: Is long-term follow-up necessary? J Am Coll Surg. 2013;1:8.</mixed-citation><mixed-citation xml:lang="en">Lee S, Skelton TS, Zheng F et al. The biopsy-proven benign thyroid nodule: Is long-term follow-up necessary? J Am Coll Surg. 2013;1:8.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Haymart MR, Repplinger DJ, Leverson GE et al. Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage. J Clin Endocrinol Metab. 2008;93:809-814.</mixed-citation><mixed-citation xml:lang="en">Haymart MR, Repplinger DJ, Leverson GE et al. Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage. J Clin Endocrinol Metab. 2008;93:809-814.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Boelaert K, Horacek J, Holder RL. Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration. J Clin Endocrinol Metab. 2006; 91:4295-4301.</mixed-citation><mixed-citation xml:lang="en">Boelaert K, Horacek J, Holder RL. Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration. J Clin Endocrinol Metab. 2006; 91:4295-4301.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Boelaert K. The association between serum TSH concentration and thyroid cancer. Endocrine-Related Cancer. 2009;16:1065-1072.</mixed-citation><mixed-citation xml:lang="en">Boelaert K. The association between serum TSH concentration and thyroid cancer. Endocrine-Related Cancer. 2009;16:1065-1072.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Fiore E, Rago T, Provenzale MA et al. Lower levels of TSH are associated to a lower risk of papillary thyroid cancer in patients with thyroid nodular disease: thyroid autonomy may play a protective role. Endocrine-Related Cancer. 2009;16:1251-1260.</mixed-citation><mixed-citation xml:lang="en">Fiore E, Rago T, Provenzale MA et al. Lower levels of TSH are associated to a lower risk of papillary thyroid cancer in patients with thyroid nodular disease: thyroid autonomy may play a protective role. Endocrine-Related Cancer. 2009;16:1251-1260.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Brewer C, Yeager N, Di CA. Thyroid-stimulating hormone initiated proliferative signals converge in vivo on the mTOR kinase without activating AKT. Cancer Research. 2007;67:8002-8006.</mixed-citation><mixed-citation xml:lang="en">Brewer C, Yeager N, Di CA. Thyroid-stimulating hormone initiated proliferative signals converge in vivo on the mTOR kinase without activating AKT. Cancer Research. 2007;67:8002-8006.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Yeager N, Klein-Szanto A, Kimura S, Di CA. Pten loss in the mouse thyroid causes goiter and follicular adenomas: insights into thyroid function and Cowden disease pathogenesis. Cancer Research. 2007;67:959-966.</mixed-citation><mixed-citation xml:lang="en">Yeager N, Klein-Szanto A, Kimura S, Di CA. Pten loss in the mouse thyroid causes goiter and follicular adenomas: insights into thyroid function and Cowden disease pathogenesis. Cancer Research. 2007;67:959-966.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Cooper DS, Doherty GM, Haugen BR et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009; 19:1167e1214.</mixed-citation><mixed-citation xml:lang="en">Cooper DS, Doherty GM, Haugen BR et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009; 19:1167e1214.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">AACE/AME/ETA Thyroid Nodule Guidelines. Endocr Pract. 2010;16:1-43.</mixed-citation><mixed-citation xml:lang="en">AACE/AME/ETA Thyroid Nodule Guidelines. Endocr Pract. 2010;16:1-43.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Ванушко В.Э., Кузнецов Н.С., Бельцевич Д.Г., и др. Прицельная тонкоигольная пункционная биопсия в диагностике рака щитовидной железы // Хирургия. 2003;10:67-72.</mixed-citation><mixed-citation xml:lang="en">Ванушко В.Э., Кузнецов Н.С., Бельцевич Д.Г., и др. Прицельная тонкоигольная пункционная биопсия в диагностике рака щитовидной железы // Хирургия. 2003;10:67-72.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Seong N. Ultrasonography-guided fine-needle aspiration of thyroid incidentaloma: Correlation with pathological findings. Clin Endocrinol. 2004;60:145-147</mixed-citation><mixed-citation xml:lang="en">Seong N. Ultrasonography-guided fine-needle aspiration of thyroid incidentaloma: Correlation with pathological findings. Clin Endocrinol. 2004;60:145-147</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
